- Home
- WKEY vs CNTX Comparison
WKEY vs CNTX Comparison
Compare WKEY & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKEY
- CNTX
- Stock Information
- Founded
- WKEY 1999
- CNTX 2015
- Country
- WKEY Switzerland
- CNTX United States
- Employees
- WKEY N/A
- CNTX N/A
- Industry
- WKEY EDP Services
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- WKEY Technology
- CNTX Health Care
- Exchange
- WKEY Nasdaq
- CNTX Nasdaq
- Market Cap
- WKEY 86.9M
- CNTX 78.0M
- IPO Year
- WKEY N/A
- CNTX 2021
- Fundamental
- Price
- WKEY $6.70
- CNTX $0.64
- Analyst Decision
- WKEY Strong Buy
- CNTX Strong Buy
- Analyst Count
- WKEY 1
- CNTX 5
- Target Price
- WKEY $4.00
- CNTX $5.50
- AVG Volume (30 Days)
- WKEY 251.7K
- CNTX 313.4K
- Earning Date
- WKEY 07-15-2025
- CNTX 08-06-2025
- Dividend Yield
- WKEY N/A
- CNTX N/A
- EPS Growth
- WKEY N/A
- CNTX N/A
- EPS
- WKEY N/A
- CNTX N/A
- Revenue
- WKEY $11,875,000.00
- CNTX N/A
- Revenue This Year
- WKEY $18.18
- CNTX N/A
- Revenue Next Year
- WKEY $112.51
- CNTX N/A
- P/E Ratio
- WKEY N/A
- CNTX N/A
- Revenue Growth
- WKEY N/A
- CNTX N/A
- 52 Week Low
- WKEY $1.61
- CNTX $0.49
- 52 Week High
- WKEY $14.00
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- WKEY 53.41
- CNTX 49.49
- Support Level
- WKEY $6.21
- CNTX $0.62
- Resistance Level
- WKEY $7.12
- CNTX $0.70
- Average True Range (ATR)
- WKEY 0.57
- CNTX 0.05
- MACD
- WKEY -0.04
- CNTX 0.01
- Stochastic Oscillator
- WKEY 75.82
- CNTX 57.14
About WKEY WISeKey International Holding Ltd
WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.